Report overview

The report records group sales of €12,353 million in 2008, up 8% at actual rates. The APP Pharmaceuticals acquisition enabled Fresenius Kabi to enter the North American IV generics market. The Group had 122,217 employees at year-end.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2008
Period: 1 January 2008 – 31 December 2008
Publication date: 18 March 2009
Language
Pages
File size
Restatement: Disclosed

Standards & Assurance

Standards

Other

Assurance

Statement included

ESG & Materiality

ESG data

Indicators available in this report:

Employees

Materiality

Assessment
Basis

Build your research dataset.

Original reports, structured indicators and machine-readable Markdown for your project.

Explore our services

Report overview

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2008
Period: 1 January 2008 – 31 December 2008
Publication date: 18 March 2009
Language
Pages
File size
Restatement: Disclosed

Standards & Assurance

Standards

Other

Assurance

Statement included

ESG & Materiality

ESG data

Indicators available in this report:

Employees

Materiality

Assessment
Basis

Build your research dataset.

Original reports, structured indicators and machine-readable Markdown for your project.

Explore our services

Consolidated Financial Statements and Management Report

Report overview

Document

Standards & Assurance

Standards

Assurance

ESG & Materiality

ESG data

Materiality

Build your research dataset.

Consolidated Financial Statements and Management Report

Report overview

Document

Standards & Assurance

Standards

Assurance

ESG & Materiality

ESG data

Materiality

Build your research dataset.